Synairgen (SNG)

Synairgen to start trial of SNG001 in COVID-19

By

[Amy Schofield]

March 20, 2020

“Synairgen to start trial of SNG001 in COVID-19”

Respiratory drug discovery and development company Synairgen has received expedited approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority (HRA) to conduct a trial of SNG001 in COVID-19 patients to potentially assist with the global outbreak of the virus. SNG001 is an inhaled formulation of interferon-beta-1a.

Would be nice to be able to get on this here with my ISA without having to go over to halifax and a basic account…

We missed the boat guys. Treatment announced this morning, share price already up 200%+ :frowning:

1 Like

Wow 300% plus rise.

500% now

Bump!